Tech Company Financing Transactions
CimCure Funding Round
CimCure, based in Amsterdam, raised $5.3 million from Positron Venture and private investors.
Transaction Overview
Company Name
Announced On
6/7/2022
Transaction Type
Venture Equity
Amount
$5,300,000
Round
Seed
Investors
Positron Venture (Lead Investor) (Joseph Peeraer)
private investors (Tom Würdinger)
Proceeds Purpose
Funds will be used to further advance the cancer vaccine up until phase 1-2 clinical trials in humans
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Servicepunt/Personeelsbalie
Amsterdam, 1081 HV
Netherlands
Amsterdam, 1081 HV
Netherlands
Phone
Website
Email Address
Overview
CimCure aims to offer efficient treatment of cancer without side effects. CimCure developed a novel immunotherapy strategy that is based on vaccination against cancer. CimCure's vaccines are effective, even at late a stage of disease, and remain effective for long-term and safe treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Diederik Engbersen
Chief Scientific Officer
Arjan Griffioen
Browse more venture capital transactions:
Prev: 6/7/2022: SkySquad venture capital transaction
Next: 6/7/2022: Let's Do This venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs